BTK and PI3K Inhibitors Reveal Synergistic Inhibitory Anti-Tumoral Effects in Canine Diffuse Large B-Cell Lymphoma Cells

Bruton's tyrosine kinase (BTK) and phosphoinositide 3-kinase (PI3K) in the B-cell receptor (BCR) signaling pathway are considered potential therapeutic targets for the treatment of B-cell lymphomas, among which, diffuse large B-cell lymphoma (DLBCL) is the most common type. Herein, we comparati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular sciences 2021-11, Vol.22 (23), p.12673
Hauptverfasser: Kong, Weibo, Sender, Sina, Taher, Leila, Villa-Perez, Simon, Ma, Yixuan, Sekora, Anett, Ruetgen, Barbara C, Brenig, Bertram, Beck, Julia, Schuetz, Ekkehard, Junghanss, Christian, Nolte, Ingo, Murua Escobar, Hugo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!